Clinical Trials Browser

Disease × Bortezomib × Plasma cell × Clear all

NCT01190787 2024-01-23

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

Phase 2 Completed

Disease, Multiple Myeloma